Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
19.5M
-
Shares change
-
+5.41M
-
Total reported value, excl. options
-
$60.8M
-
Value change
-
+$17.1M
-
Number of buys
-
17
-
Number of sells
-
-18
-
Price
-
$3.12
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2016
43 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q3 2016.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.5M shares
of 114M outstanding shares and own 17.04% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (5.33M shares), FMR LLC (4.31M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2.83M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), Redmile Group, LLC (1.43M shares), VANGUARD GROUP INC (688K shares), EcoR1 Capital, LLC (591K shares), Board of Trustees of The Leland Stanford Junior University (291K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (250K shares), and Lombard Odier Asset Management (USA) Corp (246K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.